Victrex plc (LON:VCT) Stock Has Average Target Price of GBX 807.86 According to Analysts

Shares of Victrex plc (LON:VCT) have received a consensus rating of “Hold” from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is GBX 807.86.

A number of research firms have recently issued reports on VCT. JPMorgan Chase & Co. raised their price target on Victrex from GBX 625 to GBX 785 and gave the stock a “neutral” rating in a research note on Thursday, September 10th. Berenberg Bank upped their price target on shares of Victrex from GBX 680 to GBX 870 and gave the company a “hold” rating in a research report on Friday, September 11th. Canaccord Genuity Group increased their price objective on shares of Victrex from GBX 725 to GBX 1,050 and gave the stock a “buy” rating in a research note on Tuesday, September 29th. Citigroup increased their price objective on shares of Victrex from GBX 700 to GBX 1,000 and gave the stock a “neutral” rating in a research note on Friday, September 11th. Finally, Jefferies Financial Group reissued a “hold” rating and issued a GBX 595 price objective on shares of Victrex in a report on Friday, September 25th.

Victrex Trading Down 0.5%

Victrex stock opened at GBX 907 on Monday. The company has a debt-to-equity ratio of 21.30, a current ratio of 2.35 and a quick ratio of 1.99. Victrex has a one year low of GBX 515 and a one year high of GBX 1,024. The stock has a market capitalization of £790.50 million, a PE ratio of -40.49, a price-to-earnings-growth ratio of 1.92 and a beta of 0.76. The business’s fifty day moving average is GBX 915.82 and its 200 day moving average is GBX 726.94.

About Victrex

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.